NCT06580002View on ClinicalTrials.gov

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Breast CancerSarcomaGastric CancerLung CancerHead and Neck CancerColorectal CancerOvarian CancerLiver CancerGenitourinary CancerGynecologic Cancer
Interventions
DRUG

Riluzole

Given PO

DRUG

Placebo

Given PO

Trial Locations (1)

92868

RECRUITING

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER